PRECAST COMMERCIAL POLYACRYLAMIDE GELS FOR SEPARATION OF DNA AMPLIFICATES BY TEMPERATURE-GRADIENT GEL-ELECTROPHORESIS - APPLICATION TO CLONALITY ANALYSIS OF LYMPHOMAS
M. Suttorp et al., PRECAST COMMERCIAL POLYACRYLAMIDE GELS FOR SEPARATION OF DNA AMPLIFICATES BY TEMPERATURE-GRADIENT GEL-ELECTROPHORESIS - APPLICATION TO CLONALITY ANALYSIS OF LYMPHOMAS, Electrophoresis, 17(4), 1996, pp. 672-677
The third complementary determining region (CDR-III) of the rearranged
immunoglobulin heavy chain (IgH) genes represents a unique marker for
a lymphocyte and its clonal descendants and can be amplified by the p
olymerase chain reaction (PCR) technique. This approach has markedly e
nhanced the sensitivity for detection of clonal lymphocyte populations
in patients with malignant B-lymphoid neoplasias. To monitor minimal
residual disease (MRD) in tissue specimens during or after antineoplas
tic treatment, the problem of detecting the presence of a few clonal (
malignant) lymphocytes in coexistence with a majority of polyclonal ly
mphocytes has to be addressed. Semi-nested PCR amplification of CDR-II
I rearrangements from specimen infiltrated by tumor cells generates cl
onal signals in front of a polyclonal background, and therefore high r
esolution electrophoretic techniques for separation of DNA fragments a
re required. Temperature gradient gel electrophoresis (TGGE) resolving
DNA homo- and heteroduplexes according to their thermal stability has
been successfully applied for this purpose using special electrophore
tic equipment. We describe an adjustment to this technique by using a
commercially available precast 0.5 mm thick polyacrylamide gel and by
changing a standard horizontal electrophoretic device into a TGGE devi
ce. By this means we screened patients with B-cell lymphoma undergoing
high-dosage radiochemotherapy followed by autologous transplantation
for continuous presence of clonal (tumor-specific) CDR-III rearrangeme
nts. Specimens from blood and bone marrow were collected on diagnosis
as well as before and after autologous transplantation. In addition, t
he autograft (bone marrow or peripheral blood hematopoietic stem cells
) was analyzed. Tumor cells were easily detected in the transplants an
d in specimens collected during follow-up examinations. The clinical v
alue of these findings remains unclear as yet because the number of ca
ses investigated was small and the follow-up time is still too short.
However, we conclude that the technique of combining the sensitivity o
f PCR with the specificity of high resolution TGGE is easy to use, mak
ing it possible to handle, in a clinical routine, a great number of sa
mples within a short time in order to monitor MRD in patients with B-c
ell neoplasias.